» Authors » Shelly L Carter

Shelly L Carter

Explore the profile of Shelly L Carter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 1584
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin J, et al.
Lancet Haematol . 2015 Dec; 2(9):e367-75. PMID: 26685770
Background: The optimum preparative regimen for unrelated donor marrow transplantation in patients with severe aplastic anaemia remains to be established. We investigated whether the combination of fludarabine, anti-thymocyte globulin, and...
2.
Bolanos-Meade J, Logan B, Alousi A, Antin J, Barowski K, Carter S, et al.
Blood . 2014 Aug; 124(22):3221-7. PMID: 25170121
Corticosteroids are the accepted primary therapy for acute graft-versus-host disease (GVHD), but durable responses are seen in only about half of the patients. Blood and Marrow Transplant Clinical Trials Network...
3.
Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D, et al.
Blood . 2014 Jul; 124(8):1372-7. PMID: 24982504
Grades 2-4 acute graft-versus-host disease (GVHD) occurs in approximately 35% of matched, related donor (MRD) allogeneic hematopoietic cell transplantation (HCT) recipients. We sought to determine if the combination of tacrolimus...
4.
Yanik G, Horowitz M, Weisdorf D, Logan B, Ho V, Soiffer R, et al.
Biol Blood Marrow Transplant . 2014 Mar; 20(6):858-64. PMID: 24607553
Idiopathic pneumonia syndrome (IPS) is a diffuse, noninfectious lung injury that occurs acutely after allogeneic hematopoietic cell transplantation (HCT). IPS-related mortality has been historically high (>50%) despite treatment with systemic...
5.
Giralt S, McCarthy P, Anderson K, Carter S, Richardson P, Rajkumar S, et al.
Biol Blood Marrow Transplant . 2013 Apr; 19(6):858-9. PMID: 23545332
No abstract available.
6.
Anasetti C, Logan B, Lee S, Waller E, Weisdorf D, Wingard J, et al.
N Engl J Med . 2012 Oct; 367(16):1487-96. PMID: 23075175
Background: Randomized trials have shown that the transplantation of filgrastim-mobilized peripheral-blood stem cells from HLA-identical siblings accelerates engraftment but increases the risks of acute and chronic graft-versus-host disease (GVHD), as...
7.
Tolar J, Deeg H, Arai S, Horwitz M, Antin J, McCarty J, et al.
Biol Blood Marrow Transplant . 2012 May; 18(7):1007-11. PMID: 22546497
Excessive adverse events were encountered in a Phase I/II study of cyclophosphamide (CY) dose deescalation in a fludarabine-based conditioning regimen for bone marrow transplantation from unrelated donors in patients with...
8.
Brunstein C, Fuchs E, Carter S, Karanes C, Costa L, Wu J, et al.
Blood . 2011 Apr; 118(2):282-8. PMID: 21527516
The Blood and Marrow Transplant Clinical Trials Network conducted 2 parallel multicenter phase 2 trials for individuals with leukemia or lymphoma and no suitable related donor. Reduced intensity conditioning (RIC)...
9.
Wingard J, Carter S, Walsh T, Kurtzberg J, Small T, Baden L, et al.
Blood . 2010 Sep; 116(24):5111-8. PMID: 20826719
Invasive fungal infection (IFI) is a serious threat after allogeneic hematopoietic cell transplant (HCT). This multicenter, randomized, double-blind trial compared fluconazole (N = 295) versus voriconazole (N = 305) for...
10.
Kurtzberg J, Prasad V, Carter S, Wagner J, Baxter-Lowe L, Wall D, et al.
Blood . 2008 Aug; 112(10):4318-27. PMID: 18723429
Outcomes of unrelated donor cord blood transplantation in 191 hematologic malignancy children (median age, 7.7 years; median weight, 25.9 kg) enrolled between 1999 and 2003 were studied (median follow-up, 27.4...